DossierENTITY

amylin-based medicines

Coverage of amylin-based medicines in the Nexus archive.

Earliest in view: Jun 19 · 05:00 UTCMost recent: Jun 19 · 05:00 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 19 · 05:00 UTCCNBC TOP
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
Zealand Pharma's stock experienced its two worst days on record as market enthusiasm for one of its experimental drugs waned. Investors are now focusing on amylin-based medicines as a potential growth driver for the company.